Increasing evidence suggests the involvement of chronic inflammation in the progression of prostate cancer, and prostaglandin-endoperoxide synthase 2 (PTGS2), also known as cyclooxygenase-2, catalyzes the rate-limiting steps of the pathway. | Prognostic value of prostaglandin endoperoxide synthase 2 polymorphisms in prostate cancer recurrence after radical prostatectomy